Company intelligence / Profile preview

Germitec

France

Ownership: Private
Development stage: Other

Overview

Germitec specializes in UV-C high-level disinfection systems for ultrasound probes, aiming to reduce healthcare-associated infections. Recent milestones include FDA de novo approval for Chronos and significant funding for expansion in the U.S. market.

Therapeutic areas: Infectious Diseases
Modalities: Device (UV-C Disinfection Systems)
Industry: Therapeutic Medical Devices

Partnerships

Collaboration with leading medical device manufacturersFinancière ArbevelSham Innovation SantéKurma PartnersEurazeo

Beyond the preview

Go deeper on Germitec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Germitec.

Explore the full profile